Tim Morris | CFO |
Maria Fardis | President & CEO |
Igor Gorbatchevsky | VP, Clinical Science |
Boris Peaker | Cowen & Company |
Jim Birchenough | Wells Fargo Securities |
Joe Pantginis | H.C. Wainwright |
Biren Amin | Jefferies |
Mark Breidenbach | Oppenheimer |
Madhu Kumar | FBR Capital Markets |
Good afternoon and welcome to the Iovance Biotherapeutics Third Quarter 2017 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the company's request. At this time, I would like to turn the conference over to Tim Morris, Chief Financial Officer at Iovance.